101 related articles for article (PubMed ID: 24412822)
1. Ki67 in breast cancer: a useful prognostic marker?
Caldarella A; Crocetti E; Paci E
Ann Oncol; 2014 Feb; 25(2):542. PubMed ID: 24412822
[No Abstract] [Full Text] [Related]
2. Reply to Ki67 in breast cancer: a useful prognostic marker!
Denkert C; von Minckwitz G
Ann Oncol; 2014 Feb; 25(2):542-3. PubMed ID: 24431345
[No Abstract] [Full Text] [Related]
3. Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial.
Denkert C; Loibl S; Müller BM; Eidtmann H; Schmitt WD; Eiermann W; Gerber B; Tesch H; Hilfrich J; Huober J; Fehm T; Barinoff J; Jackisch C; Prinzler J; Rüdiger T; Erbstösser E; Blohmer JU; Budczies J; Mehta KM; von Minckwitz G
Ann Oncol; 2013 Nov; 24(11):2786-93. PubMed ID: 23970015
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Factors for Luminal B-like Breast Cancer.
Ding NH; Liu CF; Hu C; Yuan JQ; Liao WH; Xiao Z
Curr Med Sci; 2019 Jun; 39(3):396-402. PubMed ID: 31209809
[TBL] [Abstract][Full Text] [Related]
5. Ki67 index in intrinsic breast cancer subtypes and its association with prognostic parameters.
Hashmi AA; Hashmi KA; Irfan M; Khan SM; Edhi MM; Ali JP; Hashmi SK; Asif H; Faridi N; Khan A
BMC Res Notes; 2019 Sep; 12(1):605. PubMed ID: 31547858
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the predictive role of pretreatment Ki-67 and Ki-67 changes in breast cancer patients receiving neoadjuvant chemotherapy according to the molecular classification: a retrospective study of 1010 patients.
Chen R; Ye Y; Yang C; Peng Y; Zong B; Qu F; Tang Z; Wang Y; Su X; Li H; Yang G; Liu S
Breast Cancer Res Treat; 2018 Jul; 170(1):35-43. PubMed ID: 29480449
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral Heterogeneity in Breast Cancer: A Comparison of Primary and Metastatic Breast Cancers.
Shi YJ; Tsang JY; Ni YB; Tse GM
Oncologist; 2017 Apr; 22(4):487-490. PubMed ID: 28341760
[TBL] [Abstract][Full Text] [Related]
8. Correlations between HER2 Expression and Other Prognostic Factors in Breast Cancer: Inverse Relations with the Ki-67 Index and P53 Status.
Payandeh M; Shahriari-Ahmadi A; Sadeghi M; Sadeghi E
Asian Pac J Cancer Prev; 2016; 17(3):1015-8. PubMed ID: 27039719
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers in the management of breast cancer: great expectations, hard times.
Bertelli G; Nelmes DJ; Al-Allak A
Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):481-4. PubMed ID: 24220569
[TBL] [Abstract][Full Text] [Related]
10. Changes of breast cancer staging when AJCC prognostic staging manual is used: a retrospective analysis of a Chinese cohort.
Ding J; Wu W; Fang J; Chu Y; Zheng S; Jiang L
Int J Biol Markers; 2018 May; 33(2):168-173. PubMed ID: 28967067
[TBL] [Abstract][Full Text] [Related]
11. Combined Detection of HER2, Ki67, and GSTP1 Genes on the Diagnosis and Prognosis of Breast Cancer.
Song B; Wang L; Zhang Y; Li N; Dai H; Xu H; Cai H; Yan J
Cancer Biother Radiopharm; 2019 Mar; 34(2):85-90. PubMed ID: 30585764
[TBL] [Abstract][Full Text] [Related]
12. Multiplex detection of breast cancer biomarkers using plasmonic molecular sentinel nanoprobes.
Wang HN; Vo-Dinh T
Nanotechnology; 2009 Feb; 20(6):065101. PubMed ID: 19417369
[TBL] [Abstract][Full Text] [Related]
13. Use of adjuvant chemotherapy in hormone receptor-positive breast cancer patients with or without the 21-gene expression assay.
Park SJ; Lee MH; Kong SY; Song MK; Joo J; Kwon Y; Lee EG; Han JH; Sim SH; Jung SY; Lee S; Lee KS; Park IH; Lee ES
Breast Cancer Res Treat; 2018 Jul; 170(1):69-76. PubMed ID: 29516374
[TBL] [Abstract][Full Text] [Related]
14. Comparison of primary breast cancer and paired metastases: biomarkers discordance influence on outcome and therapy.
Ongaro E; Gerratana L; Cinausero M; Pelizzari G; Poletto E; Giangreco M; Andreetta C; Pizzolitto S; Di Loreto C; Minisini AM; Mansutti M; Russo S; Fasola G; Puglisi F
Future Oncol; 2018 Apr; 14(9):849-859. PubMed ID: 29527957
[TBL] [Abstract][Full Text] [Related]
15. Can circulating tumor cells predict resistance in metastatic breast cancer?
Mathew A; Brufsky AM; Davidson NE
Clin Cancer Res; 2015 Jun; 21(11):2421-3. PubMed ID: 25645864
[TBL] [Abstract][Full Text] [Related]
16. Inverse relationship between Ki67 and survival in early luminal breast cancer: confirmation in a multivariate analysis.
Gallardo A; Garcia-Valdecasas B; Murata P; Teran R; Lopez L; Barnadas A; Lerma E
Breast Cancer Res Treat; 2018 Jan; 167(1):31-37. PubMed ID: 28865009
[TBL] [Abstract][Full Text] [Related]
17. Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancer.
Paoletti C; Muñiz MC; Thomas DG; Griffith KA; Kidwell KM; Tokudome N; Brown ME; Aung K; Miller MC; Blossom DL; Schott AF; Henry NL; Rae JM; Connelly MC; Chianese DA; Hayes DF
Clin Cancer Res; 2015 Jun; 21(11):2487-98. PubMed ID: 25381338
[TBL] [Abstract][Full Text] [Related]
18. Comparison of central laboratory assessments of ER, PR, HER2, and Ki67 by IHC/FISH and the corresponding mRNAs (ESR1, PGR, ERBB2, and MKi67) by RT-qPCR on an automated, broadly deployed diagnostic platform.
Wu NC; Wong W; Ho KE; Chu VC; Rizo A; Davenport S; Kelly D; Makar R; Jassem J; Duchnowska R; Biernat W; Radecka B; Fujita T; Klein JL; Stonecypher M; Ohta S; Juhl H; Weidler JM; Bates M; Press MF
Breast Cancer Res Treat; 2018 Nov; 172(2):327-338. PubMed ID: 30120700
[TBL] [Abstract][Full Text] [Related]
19. Bcl2 and Ki67 refine prognostication in luminal breast cancers.
Chen LY; Tsang JY; Ni YB; Chan SK; Chan KF; Zhang S; Tse GM
Breast Cancer Res Treat; 2015 Feb; 149(3):631-43. PubMed ID: 25648135
[TBL] [Abstract][Full Text] [Related]
20. Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreement.
Koopman T; Buikema HJ; Hollema H; de Bock GH; van der Vegt B
Breast Cancer Res Treat; 2018 May; 169(1):33-42. PubMed ID: 29349710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
